CTI BioPharma Cash Flow Statement

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	1,531	1,595	850	1,048	-742	Upgrade
Depreciation & Amortization	127	117	94	107	131	Upgrade
Other Amortization	184	156	143	140	150	Upgrade
Gain (Loss) on Sale of Assets	-7	8	-1	-2	-13	Upgrade
Gain (Loss) on Sale of Investments	-	-1	72	41	41	Upgrade
Total Asset Writedown	142	105	92	19	229	Upgrade
Provision for Credit Losses	90	419	188	-147	1,061	Upgrade
Change in Trading Asset Securities	-3,195	-2,414	1,565	-2,701	-902	Upgrade
Change in Other Net Operating Assets	2,343	-5,290	397	7,301	-2,396	Upgrade
Other Operating Activities	624	635	353	303	164	Upgrade
Operating Cash Flow	1,829	-4,680	3,729	6,193	-2,058	Upgrade
Operating Cash Flow Growth	-	-	-39.79%	-	-	Upgrade
Capital Expenditures	-140	-116	-104	-73	-54	Upgrade
Sale of Property, Plant and Equipment	39	40	45	22	25	Upgrade
Cash Acquisitions	-	-	-281	-	-	Upgrade
Investment in Securities	-99	-624	5,257	1,296	-1,934	Upgrade
Income (Loss) Equity Investments	-34	-25	-40	-5	4	Upgrade
Purchase / Sale of Intangibles	-380	-297	-264	-247	-229	Upgrade
Other Investing Activities	36	34	3	-	16	Upgrade
Investing Cash Flow	-557	-960	4,686	842	-2,111	Upgrade
Long-Term Debt Issued	498	-	843	498	-	Upgrade
Long-Term Debt Repaid	-357	-172	-1,144	-46	-270	Upgrade
Net Debt Issued (Repaid)	141	-172	-301	452	-270	Upgrade
Issuance of Common Stock	595	-	-	-	966	Upgrade
Repurchase of Common Stock	-1,038	-125	-50	-	-	Upgrade
Common Dividends Paid	-1,035	-294	-123	-68	-25	Upgrade
Total Dividends Paid	-1,035	-294	-123	-68	-25	Upgrade
Net Increase (Decrease) in Deposit Accounts	810	288	-2,100	13,564	6,212	Upgrade
Other Financing Activities	-146	-220	-100	-91	-883	Upgrade
Financing Cash Flow	-673	-523	-2,674	13,857	6,000	Upgrade
Foreign Exchange Rate Adjustments	-66	-38	170	-226	108	Upgrade
Net Cash Flow	533	-6,201	5,911	20,666	1,939	Upgrade
Free Cash Flow	1,689	-4,796	3,625	6,120	-2,112	Upgrade
Free Cash Flow Growth	-	-	-40.77%	-	-	Upgrade
Free Cash Flow Margin	39.12%	-117.29%	122.59%	192.15%	-138.49%	Upgrade
Free Cash Flow Per Share	1.65	-4.52	3.38	5.69	-1.97	Upgrade
Cash Interest Paid	146	110	92	84	98	Upgrade
Cash Income Tax Paid	113	58	72	87	56	Upgrade

Updated Feb 24, 2025. Source: S&P Global Market Intelligence. Banks template. Financial Sources.